Lilly Zyprexa IM Agitation Use Should Be Limited To Patients Studied In Trials

Lilly's antipsychotic Zyprexa intramuscular injection is safe and effective for the treatment of agitation in schizophrenia, bipolar I disorder and dementia, FDA's Psychopharmacological Drugs Advisory Committee concluded in a unanimous vote Feb. 14.

More from Archive

More from Pink Sheet